Anmeldung erfolgt in Kürze...
Details werden geladen...
Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma | The Manila Times
Advisory Committee voted 10 to 3 that the efficacy results from the IGNYTE study are evaluable and clinically meaningful
Ähnliche Seiten
Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel | The Manila Times
https://www.manilatimes.net/2026/07/30/tmt-newswire/globenewswire/capricor-therapeutics-provides-update-on-fda-advisory-committee-meeting-for-deramiocel/2395197EPH European Property Holdings PLC announces Outcome of the Annual General Meeting | The Manila Times
https://www.manilatimes.net/2026/06/18/tmt-newswire/globenewswire/eph-european-property-holdings-plc-announces-outcome-of-the-annual-general-meeting/2367842
Erdene Announces Results of Annual General and Special Meeting | The Manila Times
https://www.manilatimes.net/2026/05/29/tmt-newswire/globenewswire/erdene-announces-results-of-annual-general-and-special-meeting/2354466Microbiotica Announces Positive Results from its Phase 1b Trial (MELODY-1) of MB097, a Precision Microbiome Co-Therapy in Advanced Melanoma | The Manila Times
https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/microbiotica-announces-positive-results-from-its-phase-1b-trial-melody-1-of-mb097-a-precision-microbiome-co-therapy-in-advanced-melanoma/2345933CAPREIT Announces Results of 2026 Annual Meeting | The Manila Times
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/capreit-announces-results-of-2026-annual-meeting/2357401